<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02532361</url>
  </required_header>
  <id_info>
    <org_study_id>18473</org_study_id>
    <nct_id>NCT02532361</nct_id>
  </id_info>
  <brief_title>Proportion of Hysterectomy After Female Sterilization</brief_title>
  <official_title>A Retrospective Analysis to Describe the Proportion of Hysterectomy After Female Sterilization With Hysteroscopic Device or Tubal Ligation Using Intermountain Healthcare Database in the US</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to describe the proportion of hysterectomy in patients that
      had undergone sterilization through hysteroscopic device placement and the patients that had
      undergone sterilization through tubal ligation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients having hysterectomy procedure post-sterilization through hysteroscopic device placement</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
    <description>The study will also describe sub-outcomes related to post-sterilization hysterectomy procedure including: i. Average time (in days) from index date (sterilization) to hysterectomy ii. Percentage of patients having hysterectomy (abdominal) iii. Percentage of patients having hysterectomy (vaginal) iv. Percentage of patients having hysterectomy (laproscopically assisted vaginal hysterectomy - LAVH) v. Percentage of patients having hysterectomy (abdominal, vaginal and LAVH)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients having hysterectomy procedure post-sterilization through through tubal ligation</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
    <description>The study will also describe sub-outcomes related to post-sterilization hysterectomy procedure including: i. Average time (in days) from index date (sterilization) to hysterectomy ii. Percentage of patients having hysterectomy (abdominal) iii. Percentage of patients having hysterectomy (vaginal) iv. Percentage of patients having hysterectomy (laproscopically assisted vaginal hysterectomy - LAVH) v. Percentage of patients having hysterectomy (abdominal, vaginal and LAVH)</description>
  </primary_outcome>
  <other_outcome>
    <measure>Percentage of patients having unintended pregnancy post-sterilization</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
    <description>Exclusion of any IVF pregnancy, and any pregnancy preceding sterilization</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of patients having unintended ectopic pregnancy post-sterilization</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
    <description>Exclusion of any IVF pregnancy, and any pregnancy preceding sterilization</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of patients that have salpingectomy (unilateral, bilateral) subsequent to sterilization</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Average time in days from sterilization to salpingectomy and Kaplan-Meier-Estimator curve (number of occurrence over time)</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Average time in days from sterilization to removal of device inserts other than hysterectomy or salpingectomy and Kaplan-Meier-Estimator curve (number of occurrence over time)</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of patients with repeat sterilization surgery</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Average time in days from first sterilization to repeat sterilization surgery and Kaplan-Meier-Estimator curve (number of occurrence over time)</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of patients who undergo a Modified Hysterosalpingogram (HSG) test</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of patients who did not have a Modified HSG and unintentionally got pregnant</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of patients having readmission within 30 days of sterilization</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of patients having removal of device inserts other than hysterectomy or salpingectomy</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of patients who had Modified HSG and got pregnant</measure>
    <time_frame>Retrospective analysis of 10 year period</time_frame>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">10578</enrollment>
  <condition>Hysterectomy</condition>
  <arm_group>
    <arm_group_label>Cohort 1 / Hysteroscopic device placement</arm_group_label>
    <description>Patients that had undergone sterilization through hysteroscopic device placement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2 / Tubal ligation</arm_group_label>
    <description>Patients that had undergone sterilization through tubal ligation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hysteroscopic device placement including Essure (ESS305, BAY1454032)</intervention_name>
    <description>Essure is a permanent, minimally invasive, non-hormonal implantable device used for contraception and Adiana sterilization method is a combination of controlled thermal damage to the lining of the fallopian tube followed by insertion of a non-absorbable biocompatible silicone elastomer matrix within the tubal lumen</description>
    <arm_group_label>Cohort 1 / Hysteroscopic device placement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tubal ligation</intervention_name>
    <description>Tubal ligation or tubectomy is a surgical procedure for sterilization in which a woman's fallopian tubes are clamped and blocked, or severed and sealed, either method of which prevents eggs from reaching the uterus for implantation</description>
    <arm_group_label>Cohort 2 / Tubal ligation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women aged 18 - 49 at index date who underwent hysteroscopic device sterilization procedure
        or tubal ligation sterilization procedure.

        Index date: Date of sterilization procedure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 18 to 49 years at index date

          -  Gender: Female

          -  Diagnosis: Women who underwent hysteroscopic device sterilization procedure

          -  Diagnosis: Women who underwent tubal ligation sterilization procedure (includes
             laparoscopic tubal ligation), and salpingectomy

        Exclusion Criteria:

          -  Patients undergoing in-vitro fertilization (IVF) procedures

          -  Embryo transfer, intrauterine

          -  Follicle puncture for oocyte retrieval, any method
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>New Jersey</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm</url>
    <description>Click here and search for drug information provided by the FDA.</description>
  </link>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.</description>
  </link>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2015</study_first_submitted>
  <study_first_submitted_qc>August 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2015</study_first_posted>
  <last_update_submitted>December 22, 2016</last_update_submitted>
  <last_update_submitted_qc>December 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sterilization</keyword>
  <keyword>Hysteroscopic Device Placement</keyword>
  <keyword>Tubal Ligation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

